on the mechanisms of the antibody-mediated neuronal abnormalities leading to brain pathology and to hormonal serum alterations in lupus. Projects include the function of the blood-brain barrier in the antibody-mediated pathology of the adult brain and of the maternal antibody- mediated abnormalities in the developing brain. focus is to discover and validate new biomarkers for early detection, prediction of disease course and outcome and treatment response in cancer, particularly breast and ovarian cancers. is to identify regulatory mechanisms of inflammatory function of dendritic cells under both homeostatic and inflammatory conditions. This is with the goal to understand the molecular mechanisms that inhibit the development of autoimmune diseases, particularly in lupus and inflammatory bowel diseases. biomarkers, especially novel genetic technologies, to better understand the causes and treatment of schizophrenia. He develops and implements strategies for identifying relationships between genetic variation and psychiatric disease, and examines the role that schizophrenia risk genes play in brain structure, function and development. focuses on elucidating the biology of behavioral disturbances in Alzheimer's disease and the development of novel treatments. Recent work has focused on the endocannabinoid system in Alzheimer's disease and the contribution of abnormal tau protein deposition to the development of psychotic symptoms. and assists investigators in data analysis, research question formulation, study design, data management, storage and retrieval, as well as publication preparation and patient safety and data quality monitoring. on monitoring and treating the injured brain. Projects include developing the next generation brain multimodality monitoring devices using BioMEMS technology, and investigating trigeminal nerve stimulation as a novel therapeutic approach to traumatic brain injury by the activation of endogenous neuroprotective mechanisms. research is the elucidation of the genetics and pathophysiology of Diamond- Blackfan anemia (DBA), a disorder of the bone marrow. He is working with numerous collaborators to develop genotype-phenotype correlations, resulting in the discovery of a number of DBA genotypes. |